Recent Quotes
My Watchlist
Indicators
Local Stocks
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about HRTS

Recent news which mentions HRTS

EXCLUSIVE: Novo Nordisk Faces Political Heat Over Weight-Loss Drug Prices Ahead Of Elections, Yet 'The Real Issue Is With The Middlemen'
Tickers HRTS NVO
Tags Analyst Color Market News Large Cap
From Benzinga
Disruptive Theme of the Week: Playing Defense
Tickers FSTA HRTS IHE ITA
Tags PPA IYH VDC
From ETF Trends
EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'
Tickers AMGN AZN HRTS LLY
Tags Top Stories NVO AMGN
From Benzinga
EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO
Tickers ABBV ALNY AMGN HRTS
Tags HRTS glp/1 Weight Loss
From Benzinga
Weight-Loss Drug Forecasts Skyrocket To $150B As Novo Nordisk, Eli Lilly Ramp Up Supply
Tickers HRTS LLY NEWS NVO
Tags HRTS obesity Benzinga
From Benzinga
Fighting Obesity Using ETFs
Tickers HRTS IBB XLY
Tags expert insights Tema IBB
From ETF Trends
Thematic ETF Winners of the Q1 2024 Earnings Season
Tickers FCLD HRTS IVES MJ
Tags Fidelity HRTS Tema
From ETF Trends
Ozempic, Weygovy – Obesity And Heart Health Constitute A Major Market That Is Only Growing
Tickers HRTS
Tags Market News Interview Benzinga
From Benzinga
Roche, Pfizer Race To Find Next Ozempic As Pharma Giants Hustle To Join Obesity Treatment Market
Tickers ALT HRTS LLY NVO
Tags Sector ETFs Markets ALT
From Benzinga
EXCLUSIVE: Tema ETFs' Innovative Thematic Investing Approach Targets New Opportunities Beyond The Fads
Tickers CANC HRTS LUX MSFT
Tags TOLL ETFs Expert Ideas
From Benzinga
New ETF invested in Ozempic maker and exposed to other obesity drugs falls in first day of trade
Tickers AMGN ARKK BFIT COMP
Tags BFIT ARKK VRTX
From MarketWatch
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.